English edition Regulatory affairs · European Union
Planning IVDR performance evaluation for a near-patient IVD
For a manufacturer in China preparing to enter the EU, the first working document should connect each proposed claim to the evidence needed to support it.
Make the intended purpose specific
Name the analyte, condition or clinical question, target population, sample type, intended user and setting. State how the result will be used. A device intended for a trained healthcare professional near the patient and one intended for self-testing raise different questions about users and instructions.
For example, before extending a whole-blood test from a laboratory to a community setting, identify any differences in collection, operator training and environmental conditions. Decide which claims the available studies actually support and which require further evidence.
Connect each claim to a performance evaluation plan
Article 56 and Annex XIII of Regulation (EU) 2017/746 link performance evaluation to scientific validity, analytical performance and clinical performance. Build a working table with the claim, evidence source, relevant specimen and population, limitations and proposed action. A study using one specimen type needs a documented rationale before it can support claims for another.
Define the comparator, acceptance criteria, relevant user groups and handling of invalid or discordant results before collecting new data. The plan and the performance evaluation report should remain linked as evidence develops. MDCG 2022-2 provides guidance on this process.
Bring the right documents to an initial discussion
A useful technical meeting starts with the draft intended purpose, proposed classification and supporting rule, current instructions for use, device and software versions, and an inventory of performance studies. Include the countries, settings, users and specimens represented in the data. Use a list of evidence gaps to agree the questions for a laboratory or regulatory partner.
The manufacturer remains responsible for its obligations under the IVDR. A manufacturer outside the Union must designate a sole authorised representative as provided in Article 11. The applicable conformity assessment route, including any involvement of a notified body, depends on the device. Laboratory comparison data contribute to the dossier but do not confer CE marking.
For an initial enquiry, describe the device, its intended use and the evidence question. Published protocols or aggregate study summaries are useful starting points.